Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3), has acquired the STATKING Clinical Services, a provider of clinical trial services, including clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management for the regulatory approval of novel drug and medical device products.   “We are very pleased to have STA...